Global Upstream Bioprocessing Market Size, Share, and Analysis, By Product (Bioreactors/Fermenters, Cell Culture Products, Bioreactors Accessories, Filters, Bags & Containers, and Others), By Workflow (Cell Culture, Cell Separation, and Media Preparation)

Global Upstream Bioprocessing Market Size, Share, and Analysis, By Product (Bioreactors/Fermenters, Cell Culture Products, Bioreactors Accessories, Filters, Bags & Containers, and Others), By Workflow (Cell Culture, Cell Separation, and Media Preparation), By Use Type (Multi-use and Single-use), By Mode (In-house and Outsourced), By End-User (Biopharmaceutical Companies, CDMO & CROs, Research & Academic Institutes, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

PRODUCT OVERVIEW

Global Upstream Bioprocessing Market is projected to exhibit a Compound Annual Growth Rate (CAGR) of 14.4% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 12.4 billion and is projected to reach USD 54.4 billion by the completion of 2034.

Upstream bioprocessing refers to the early stages of producing biopharmaceutical products, like therapeutic proteins, vaccines, or antibodies. It includes the process of growing living cells (such as bacteria, yeast, or mammalian cells) in special bioreactors with controlled conditions. These cells have been genetically modified to make the specific biopharmaceutical product. In addition, the upstream process consists of developing cell lines, preparing media, preparing inoculum, and carrying out fermentation or cell culture. Furthermore, variables including pH, temperature, oxygenation, and nutrient availability are observed and adjusted to improve the cell growth and increase the output of production. Thus, the initial stage is important as it lays the groundwork for the subsequent processing steps, in which the desired product is isolated and transformed into its final form for consumption.

MARKET HIGHLIGHTS

Global upstream bioprocessing market is predicted to achieve a value of USD 54.4 billion in the forecasted period, due to the growing need for biopharmaceuticals as a result of the increasing incidence of chronic illnesses and an aging population on a global scale. The need for bioprocessing technologies is pushed by the growth of innovative therapies and personalized medicine methods. Moreover, innovations in bioprocessing technologies like single-use systems and high-throughput screening methods are also impacting the market. The government's initiatives and laws that promote biopharmaceutical innovation also help to boost the worldwide demand for the upstream bioprocessing market. Therefore, the upstream bioprocessing industry is expected to grow further due to the increasing demand for biopharmaceuticals and ongoing innovations in bioprocessing technology.

Global Upstream Bioprocessing Market Segments:

• By Product
• Bioreactors/Fermenters
• Cell Culture Products
• Bioreactors Accessories
• Filters
• Bags & Containers
• Others
• By Workflow
• Cell Culture
• Cell Separation
• Media Preparation
• Others
• By Use Type
• Multi-use
• Single-use
• By Mode
• In-house
• Outsourced
• By End-User
• Biopharmaceutical companies
• CDMO and CROs
• Research and academic institutes
• Others

MARKET DYNAMICS

Growth Drivers

Advancements in Biotechnology are Expected to Foster Market Expansion

Increasing Demand for Personalized Medicine and Targeted Therapies Will Aid in the Adoption of Upstream Bioprocessing Market

Restraint

High Cost and Complexity Associated with Bioprocessing Equipment

Key Players

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Sartorius AG
• Danaher Corporation
• GE Healthcare
• Lonza Group Ltd.
• Eppendorf AG
• Corning Incorporated
• Applikon Biotechnology BV
• PBS Biotech, Inc.
• Novasep Holding SAS
• Fujifilm Diosynth Biotechnologies (a subsidiary of Fujifilm Holdings Corporation)
• MilliporeSigma (the Life Science business of Merck KGaA)
• Bio-Rad Laboratories, Inc.
• Repligen Corporation
• Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)

Global Laboratory Temperature Control Units Market is further segmented by region into:

• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 3-month post-sales analyst support.

*Please Note: The report will be delivered in 2-3 business days upon order confirmation*